AIMC Journal:
CNS drugs

Showing 1 to 2 of 2 articles

Enhancing Drug Response Prediction in Epilepsy with Emerging Multimodal Models: Focus on Clinical, Pharmacologic, and Genomic Factors.

CNS drugs
Epilepsy is a common neurological disorder, with approximately one-third of the affected population developing drug-resistant epilepsy despite the exponentially increasing number of antiseizure medications (ASMs) that are available. Current ASM selec...

Comparative Mortality Risk of Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Alzheimer's Disease: A Real‑World Retrospective Cohort Study with Treatment Effect Heterogeneity Analysis.

CNS drugs
BACKGROUND: Second-generation antipsychotics (SGAs) are frequently used off-label to manage behavioral symptoms in Alzheimer's disease (AD), despite ongoing concerns about their safety. Comparative evidence on mortality risk across specific SGAs rema...